The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD

References

• VogelmeierCF, CrinerGJ, MartinezFJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP28128970
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Health Organization (WHO) website. 2019 Available from: http://www.who.int. Accessed 1014, 2019.
   Google Scholar
• KesslerR, PartridgeMR, MiravitllesM, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–272. doi:10.1183/09031936.0005111021115606
   PubMed Web of Science ®Google Scholar
• PartridgeMR, KarlssonN, SmallIR, et al. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin. 2009;25(8):2043–2048. doi:10.1185/0300799090310300619569976
   PubMed Web of Science ®Google Scholar
• JudithJS, QianC, MichelleM, et al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577–586. doi:10.2147/COPD.S7615725844033
   PubMed Web of Science ®Google Scholar
• MiravitllesM, WorthH, Soler CataluñaJJ, et al. Observational study to characterise 24-hour COPD symptoms and their relationship with patient-reported outcomes: results from the ASSESS study. Respir Res. 2014;15(122):119–129. doi:10.1186/s12931-014-0122-125287584
   PubMed Web of Science ®Google Scholar
• MiravitllesM, IzquierdoJL, EsquinasC, et al. The variability of respiratory symptoms and associated factors in COPD. Respir Med. 2017;129:165–172. doi:10.1016/j.rmed.2017.06.01728732827
   PubMed Web of Science ®Google Scholar
• KuyucuT, GüçlüSZ, SaylanB, et al. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Tuberk Toraks. 2011;59(4):328–339. doi:10.5578/tt.326822233302
   PubMedGoogle Scholar
• Soler-CataluñaJJ, SauledaJ, ValdésL, et al. Prevalence and perception of 24-hour symptom patterns in patients with stable chronic obstructive pulmonary disease in Spain. Arch Bronconeumol. 2016;52(6):308–315. doi:10.1016/j.arbres.2015.11.01026774700
   PubMed Web of Science ®Google Scholar
• RocheN, SmallM, BroomfieldS, et al. Real world COPD: association of morning symptoms with clinical and patient reported outcomes. COPD. 2013;10(6):679–686. doi:10.3109/15412555.2013.84478424127914
   PubMedGoogle Scholar
• TsiligianniI, MettingE, van der MolenT, et al. Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. NPJ Prim Care Respir Med. 2016;26:16040. doi:10.1038/npjpcrm.2016.4027442618
   PubMed Web of Science ®Google Scholar
• GaryG, BrookeC, LeidyNK, et al. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD). Health Qual Life Outcomes. 2016;14(1):104–118. doi:10.1186/s12955-016-0506-727424173
   PubMed Web of Science ®Google Scholar
• MarinJM, BeehKM, ClemensA, et al. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (symptoms and pulmonary function in the moRnING). Int J Chron Obstruct Pulmon Dis. 2016;11:1425–1434. doi:10.2147/COPD.S10612727418815
   PubMed Web of Science ®Google Scholar
• PartridgeMR, MiravitllesM, StåhlE, et al. Development and validation of the capacity of daily living during the morning questionnaire and the global chest symptoms questionnaire in COPD. Eur Respir J. 2010;36(1):96–104. doi:10.1183/09031936.0012370919897551
   PubMed Web of Science ®Google Scholar
• XiaoyunL, WeiC, JiaxiD, et al. Reliability and validity of the chronic obstructive pulmonary disease morning symptom diary Chinese version. Chin J Tuberc Respir Dis. 2019;42(6):444–450.
   Google Scholar
• AnzuetoA, LeimerI, KestenS. Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009;4:245–251. doi:10.2147/copd.s486219657398
   PubMedGoogle Scholar
• MiravitllesM, FerrerM, PontA, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395. doi:10.1136/thx.2003.00873015115864
   PubMed Web of Science ®Google Scholar
• HalpinDM, DecramerM, CelliB, et al. Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:653–661. doi:10.2147/COPD.S3418623055714
   PubMed Web of Science ®Google Scholar
• Soler-CataluñaJJ, Martínez-GarcíaMA, Román SánchezP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.04052716055622
   PubMed Web of Science ®Google Scholar
• HoogendoornM, HoogenveenRT, Rutten-van MölkenMP, et al. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J. 2011;37(3):508–515. doi:10.1183/09031936.0004371020595157
   PubMed Web of Science ®Google Scholar
• LuM, WangX, CaiB, et al. Perception of circadian variation of symptoms in Chinese patients with chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(10):3888–3895. doi:10.21037/jtd.2017.08.13129268398
   PubMed Web of Science ®Google Scholar
• HurstJR, VestboJ, AnzuetoA, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa090988320843247
   PubMed Web of Science ®Google Scholar
• MoyML, TeylanM, WestonNA, et al. Daily step count predicts acute exacerbations in a US cohort with COPD. PLoS One. 2013;8(4):e60400. doi:10.1371/journal.pone.006040023593211
   PubMed Web of Science ®Google Scholar
• BeehKM, GlaabT, StowasserS, et al. Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial. Respir Res. 2013;14(1):116. doi:10.1186/1465-9921-14-11624168767
   PubMed Web of Science ®Google Scholar
• BurgelPR, Nesme-MeyerP, ChanezP, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest. 2009;135(4):975–982. doi:10.1378/chest.08-206219017866
   PubMed Web of Science ®Google Scholar
• NiewoehnerDE, LokhnyginaY, RiceK, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007;131(1):20–28. doi:10.1378/chest.06-131617218552
   PubMed Web of Science ®Google Scholar
• QuintJK, Baghai-RavaryR, DonaldsonGC, et al. Relationship between depression and exacerbations in COPD. Eur Respir J. 2008;32(1):53–60. doi:10.1183/09031936.0012010718321938
   PubMed Web of Science ®Google Scholar
• ZhouZJ, ZhouAY, ZhaoYY, et al. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis. Int J Chronic Obstr. 2018;Volume 13:1675–1682. doi:10.2147/COPD.S161225
   PubMed Web of Science ®Google Scholar
• van Buul AmandaR, Kasteleyn MariseJ, Chavannes NielsH, et al. Physical activity in the morning and afternoon is lower in patients with chronic obstructive pulmonary disease with morning symptoms. Respir Res. 2018;19:49. doi:10.1186/s12931-018-0749-429587841
   PubMed Web of Science ®Google Scholar
• van BuulAR, KasteleynMJ, ChavannesNH, et al. The association between objectively measured physical activity and morning symptoms in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2831–2840. doi:10.2147/COPD.S14338729042764
   PubMed Web of Science ®Google Scholar